HIV & AIDS Information :: News

aidsmap hiv & aids news

RSS

HIV cultured from pharynx: potential role in oral HIV transmission?

Robert Fieldhouse | 03 March 2002
Whilst debate continues about exactly how risky oral sex really is, researchers from the University of Washington in Seattle and the Imapcta Salud y Educacion, Lima, Peru have successfully cultured ...
Rosiglitazone loses its lustre: Data on HAART-associated lipodystrophy not encouraging

Anna Poppa | 01 March 2002
At the close of the Ninth Annual Retroviruses Conference in Seattle today, researchers from Helsinki presented data from the first controlled study to evaluate the use of rosiglitazone as a ...
Hard gel saquinavir equivalent to soft gel when boosted

Keith Alcorn | 28 February 2002
Hard gel saquinavir (Invirase) may return to favour after being condemned as sub-optimal in the mid-90s, following the demonstration that Invirase boosted with ritonavir produces better blood levels and is ...
Once daily lopinavir on the way

Keith Alcorn | 28 February 2002
Another protease inhibitor looks set to move to once daily dosing, according to the findings of 48 week study presented on Wednesday at the Ninth Annual Retroviruses Conference in Seattle. ...
HIV patients of less experienced physicians die faster according to Canadian cohort study

Anna Poppa | 28 February 2002
People with HIV whose doctor sees few other HIV-positive patients may survive for a shorter period than people with more experienced doctors, despite the availability of HAART. This is the ...
Pegylated interferon in HIV/HCV co-infection

Keith Alcorn | 28 February 2002
The first data on the use of pegylated interferon alpha 2a and ribavirin combination therapy for hepatitis C infection in people with HIV were presented today at the Ninth Annual ...
Viral load blips on salvage therapy don't predict failure

Keith Alcorn | 27 February 2002
Concerns that viral load blips during antiretroviral treatment for heavily treatment-experienced patients might carry a higher risk of treatment failure than in patients on their first combination may be allayed ...
Niacin reduces abdominal fat: pilot study

Keith Alcorn | 27 February 2002
The vitamin niacin (B3, or nicotinic acid), already known for its cholesterol-lowering effects, may also reduce central or abdominal fat accumulation in HIV-associated lipodystrophy, according to the results of a ...
ESPRIT reports substantial CD4 rises as enrollment passes 2,500

Anna Poppa | 27 February 2002
Preliminary data from the ongoing international ESPRIT trial show significant increases in CD4 counts amongst interleukin-2 (IL-2) recipients following three IL-2 cycles. The report coincides with the news that enrollment ...
Drug resistance: if transmitted, may persist more than 1 year

Keith Alcorn | 27 February 2002
US researchers have established that resistance to non-nucleoside reverse transcriptase inhibitors acquired at the time of HIV infection can persist for more than one year. Their findings were presented on ...

hiv & aids news selected from other sources

Employment

China: HIV job seeker to hear verdict soon

Sina | 10 November 2010

A verdict is expected to be handed down on Friday in the mainland's first court case of discrimination against an HIV-positive job seeker, the plaintiff's lawyers said on Tuesday.
UK health services

UK Spending Review acknowledges continuing importance of HIV social care

NAT | 09 November 2010

Following a recent campaign led by NAT (National AIDS Trust) to protect funding for social care services in England for people living with HIV, the Government has committed in the recent Spending Review to take account of HIV social care needs within the overall local authority grant over the next five years.
Epidemiology

Hands off!: Interview with pharmacist Janice Lee

Medecins Sans Frontieres | 09 November 2010

A pharmacist talks about why generic medicines are so important to MSF's medical teams, who work in some of the poorest places on earth.
Epidemiology

AFRICA: EU-India deal could threaten access to essential HIV drugs

IRIN Plus News | 09 November 2010

As Indian and European officials meet in Brussels to thrash out the details of a Free Trade Agreement (FTA), civil society activists are concerned the deal could mean tighter intellectual property protections that could reduce access to cheap Indian generic drugs.
TB diagnosis

TB in India: a deadly misdiagnosis

New Yorker | 09 November 2010

Is it possible to save the millions of people who die from TB?
Epidemiology and behaviour

New Zealand: "Absence of condom culture" claim disputed

GayNZ.com | 09 November 2010

A reported claim that there is currently an "absence of condom culture" amongst gay and bi men in New Zealand is being hotly disputed by the NZ AIDS Foundation which bears responsibility for promoting safe sex.
Magic Johnson Still Thriving 19 Years After Stunning The World

SB Nation | 09 November 2010

On November 7, 1991, the sports world was turned upside down when Magic Johnson abruptly retired from the Lakers. Fast forward 19 years later, and Magic is still around, which might be more stunning than his initial announcement.
Hepatitis C symptoms and diagnosis

Liver Cancer Survival Similar in HIV-Positive and HIV-Negative People

AIDSMeds | 09 November 2010

Three-year survival rates after a diagnosis of hepatocellular carcinoma (liver cancer) are similar between people living with HIV and HIV-negative people, according to a study presented at the American Association for the Study of Liver Diseases being held October 29 to November 2 in Boston.
Liver Cancer Survival Similar in HIV-Positive and HIV-Negative People

Kaiser Daily Global Health Policy Report | 09 November 2010

Three-year survival rates after a diagnosis of hepatocellular carcinoma (liver cancer) are similar between people living with HIV and HIV-negative people, according to a study presented at the American Association for the Study of Liver Diseases being held October 29 to November 2 in Boston.
Targeting amyloid to stop HIV

Eurekalert HIV | 08 November 2010

Amyloid protein structures are best known for the troubles they pose in the brains of Alzheimer's patients. Now researchers are trying to exploit their presence in a very different place -- in semen -- to find a new way to stop HIV. Scientists have created a substance that weakens the ability of HIV to infect the body's immune cells.

Latest news

aidsmap hiv & aids news

RSS

HIV cultured from pharynx: potential role in oral HIV transmission?

Rosiglitazone loses its lustre: Data on HAART-associated lipodystrophy not encouraging

Hard gel saquinavir equivalent to soft gel when boosted

Once daily lopinavir on the way

HIV patients of less experienced physicians die faster according to Canadian cohort study

Pegylated interferon in HIV/HCV co-infection

Viral load blips on salvage therapy don't predict failure

Niacin reduces abdominal fat: pilot study

ESPRIT reports substantial CD4 rises as enrollment passes 2,500

Drug resistance: if transmitted, may persist more than 1 year

More

hiv & aids news selected from other sources

China: HIV job seeker to hear verdict soon

UK Spending Review acknowledges continuing importance of HIV social care

Hands off!: Interview with pharmacist Janice Lee

AFRICA: EU-India deal could threaten access to essential HIV drugs

TB in India: a deadly misdiagnosis

New Zealand: "Absence of condom culture" claim disputed

Magic Johnson Still Thriving 19 Years After Stunning The World

Liver Cancer Survival Similar in HIV-Positive and HIV-Negative People

Liver Cancer Survival Similar in HIV-Positive and HIV-Negative People

Targeting amyloid to stop HIV

Conference news

HIV treatment update

aidsmap news iPhone app

HIV drug prescribing

aidsmap news feeds

Email updates

Latest news

aidsmap hiv & aids news

hiv & aids news selected from other sources

aidsmap news feeds

Email updates

Share/bookmark this page